Sjögren Syndrome or Sjögren Disease? The Histological and Immunological Bias Caused by the 2002 Criteria

The current 2002 classification criteria do not cover the broad clinical and immunological heterogeneity of primary Sjögren syndrome (SS), since five of the six criteria focus exclusively on glandular involvement and the remaining criterion is the mandatory presence of anti-Ro/La antibodies. The aim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical reviews in allergy & immunology 2010-04, Vol.38 (2-3), p.178-185
Hauptverfasser: Ramos-Casals, Manuel, Brito-Zerón, Pilar, Perez-De-Lis, Marta, Jimenez, Iratxe, Blanco, Maria-Jose, Bove, Albert, Soto, Maria-Jose, Akasbi, Miriam, Diaz, Candido, Sentís, Juan, Siso, Antoni
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 185
container_issue 2-3
container_start_page 178
container_title Clinical reviews in allergy & immunology
container_volume 38
creator Ramos-Casals, Manuel
Brito-Zerón, Pilar
Perez-De-Lis, Marta
Jimenez, Iratxe
Blanco, Maria-Jose
Bove, Albert
Soto, Maria-Jose
Akasbi, Miriam
Diaz, Candido
Sentís, Juan
Siso, Antoni
description The current 2002 classification criteria do not cover the broad clinical and immunological heterogeneity of primary Sjögren syndrome (SS), since five of the six criteria focus exclusively on glandular involvement and the remaining criterion is the mandatory presence of anti-Ro/La antibodies. The aim of this study was to analyze the clinical features of patients with a well-established diagnosis of primary SS who do not fulfill the 2002 classification criteria. Five hundred seven patients diagnosed with primary SS (1993 criteria) were consecutively included and followed up. Two hundred twenty-one (44%) patients did not fulfill the 2002 criteria. These patients were older at diagnosis (p 
doi_str_mv 10.1007/s12016-009-8152-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954683199</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>954683199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-195e5fdc3cf355080564e109457c27e7f908a5d6944c42f3aea075306ab456103</originalsourceid><addsrcrecordid>eNqFkctu1DAUhi0Eohd4ADZgsekqcGzHtxWC4dJKlVhMu7Y8ycngURIXO1lMH4wX4MXwKKNWYgELy9bx9__nHP2EvGLwjgHo95lxYKoCsJVhklf3T8gpk9JWwJV-Wt5goAJZ2xNylvMOgIMR9jk5YVZqY606Jbv17vevbcKRrvdjm-KANCb6UPwcMvqMH-jND6SXIU-xj9vQ-J76saVXwzCPD5VPwWe68nPGlm72dCoKXlrSVQoTpuBfkGed7zO-PN7n5Pbrl5vVZXX9_dvV6uN11dRcTVWZDWXXNqLphJRlA6lqZGBrqRuuUXcWjJetsnVdBJ3w6EFLAcpvaqkYiHNysfjepfhzxjy5IeQG-96PGOfsrKyVEcza_5JaCCF1aVzIt3-RuzinsazhLDBjmGEHiC1Qk2LOCTt3l8Lg094xcIfA3BKYK4G5Q2DuvmheH43nzYDto-KYUAH4AuTyNW4xPXb-l-ubRdT56Pw2hexu1wUSZVYueDl_AAtbqQ8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>901881817</pqid></control><display><type>article</type><title>Sjögren Syndrome or Sjögren Disease? The Histological and Immunological Bias Caused by the 2002 Criteria</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Ramos-Casals, Manuel ; Brito-Zerón, Pilar ; Perez-De-Lis, Marta ; Jimenez, Iratxe ; Blanco, Maria-Jose ; Bove, Albert ; Soto, Maria-Jose ; Akasbi, Miriam ; Diaz, Candido ; Sentís, Juan ; Siso, Antoni</creator><creatorcontrib>Ramos-Casals, Manuel ; Brito-Zerón, Pilar ; Perez-De-Lis, Marta ; Jimenez, Iratxe ; Blanco, Maria-Jose ; Bove, Albert ; Soto, Maria-Jose ; Akasbi, Miriam ; Diaz, Candido ; Sentís, Juan ; Siso, Antoni</creatorcontrib><description>The current 2002 classification criteria do not cover the broad clinical and immunological heterogeneity of primary Sjögren syndrome (SS), since five of the six criteria focus exclusively on glandular involvement and the remaining criterion is the mandatory presence of anti-Ro/La antibodies. The aim of this study was to analyze the clinical features of patients with a well-established diagnosis of primary SS who do not fulfill the 2002 classification criteria. Five hundred seven patients diagnosed with primary SS (1993 criteria) were consecutively included and followed up. Two hundred twenty-one (44%) patients did not fulfill the 2002 criteria. These patients were older at diagnosis (p &lt; 0.001) and had a lower frequency of parotid enlargement (p = 0.002), fever (p = 0.041), arthritis (p = 0.041), vasculitis (p = 0.050), peripheral neuropathy (p = 0.002), cranial nerve involvement (p = 0.015), raised erythrocyte sedimentation rate ( ESR) levels (p &lt; 0.001), anemia (p &lt; 0.001), leukopenia (p = 0.037), hypergammaglobulinemia (p &lt; 0.001), positive rheumatoid factor ( RF; p = 0.002), and cryoglobulinemia (p = 0.049) in comparison with those fulfilling 2002 criteria. However, there were no significant differences in the prevalence of sicca features, diagnostic tests, overall systemic involvement, antinuclear antibodies , complement levels, development of B-cell lymphoma, or survival. Patients with anti-Ro antibodies had the highest frequencies of systemic features, hematological abnormalities, and altered immunological markers. In conclusion, patients fulfilling the 2002 criteria, who have either a specific histological diagnosis (lymphocytic infiltration) or highly specific autoantibodies (Ro/La), might well be considered to have Sjögren “disease.” In contrast, etiopathogenic mechanisms other than lymphocytic-mediated epithelial damage could be involved in patients with negative Ro and negative biopsy, in whom the term Sjögren “syndrome” seems more adequate.</description><identifier>ISSN: 1080-0549</identifier><identifier>EISSN: 1559-0267</identifier><identifier>DOI: 10.1007/s12016-009-8152-z</identifier><identifier>PMID: 19578996</identifier><language>eng</language><publisher>New York: New York : Humana Press Inc</publisher><subject>Allergology ; Anemia ; Antibodies, Antinuclear - immunology ; Antinuclear antibodies ; Arthritis ; Autoantibodies ; Autoantibodies - immunology ; Biopsy ; Cell survival ; Classification ; Cranial nerves ; Cryoglobulinemia ; double prime B-cell lymphoma ; Erythrocytes ; Female ; Fever ; Humans ; Hypergammaglobulinemia ; Immunology ; Internal Medicine ; Leukopenia ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Peripheral neuropathy ; Practice Guidelines as Topic ; Reviews ; Rheumatoid factor ; Sedimentation ; Sjogren's syndrome ; Sjogren's Syndrome - classification ; Sjogren's Syndrome - diagnosis ; Sjogren's Syndrome - immunology ; Vasculitis</subject><ispartof>Clinical reviews in allergy &amp; immunology, 2010-04, Vol.38 (2-3), p.178-185</ispartof><rights>Humana Press Inc. 2009</rights><rights>Springer Science+Business Media, LLC 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-195e5fdc3cf355080564e109457c27e7f908a5d6944c42f3aea075306ab456103</citedby><cites>FETCH-LOGICAL-c426t-195e5fdc3cf355080564e109457c27e7f908a5d6944c42f3aea075306ab456103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12016-009-8152-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12016-009-8152-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19578996$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramos-Casals, Manuel</creatorcontrib><creatorcontrib>Brito-Zerón, Pilar</creatorcontrib><creatorcontrib>Perez-De-Lis, Marta</creatorcontrib><creatorcontrib>Jimenez, Iratxe</creatorcontrib><creatorcontrib>Blanco, Maria-Jose</creatorcontrib><creatorcontrib>Bove, Albert</creatorcontrib><creatorcontrib>Soto, Maria-Jose</creatorcontrib><creatorcontrib>Akasbi, Miriam</creatorcontrib><creatorcontrib>Diaz, Candido</creatorcontrib><creatorcontrib>Sentís, Juan</creatorcontrib><creatorcontrib>Siso, Antoni</creatorcontrib><title>Sjögren Syndrome or Sjögren Disease? The Histological and Immunological Bias Caused by the 2002 Criteria</title><title>Clinical reviews in allergy &amp; immunology</title><addtitle>Clinic Rev Allerg Immunol</addtitle><addtitle>Clin Rev Allergy Immunol</addtitle><description>The current 2002 classification criteria do not cover the broad clinical and immunological heterogeneity of primary Sjögren syndrome (SS), since five of the six criteria focus exclusively on glandular involvement and the remaining criterion is the mandatory presence of anti-Ro/La antibodies. The aim of this study was to analyze the clinical features of patients with a well-established diagnosis of primary SS who do not fulfill the 2002 classification criteria. Five hundred seven patients diagnosed with primary SS (1993 criteria) were consecutively included and followed up. Two hundred twenty-one (44%) patients did not fulfill the 2002 criteria. These patients were older at diagnosis (p &lt; 0.001) and had a lower frequency of parotid enlargement (p = 0.002), fever (p = 0.041), arthritis (p = 0.041), vasculitis (p = 0.050), peripheral neuropathy (p = 0.002), cranial nerve involvement (p = 0.015), raised erythrocyte sedimentation rate ( ESR) levels (p &lt; 0.001), anemia (p &lt; 0.001), leukopenia (p = 0.037), hypergammaglobulinemia (p &lt; 0.001), positive rheumatoid factor ( RF; p = 0.002), and cryoglobulinemia (p = 0.049) in comparison with those fulfilling 2002 criteria. However, there were no significant differences in the prevalence of sicca features, diagnostic tests, overall systemic involvement, antinuclear antibodies , complement levels, development of B-cell lymphoma, or survival. Patients with anti-Ro antibodies had the highest frequencies of systemic features, hematological abnormalities, and altered immunological markers. In conclusion, patients fulfilling the 2002 criteria, who have either a specific histological diagnosis (lymphocytic infiltration) or highly specific autoantibodies (Ro/La), might well be considered to have Sjögren “disease.” In contrast, etiopathogenic mechanisms other than lymphocytic-mediated epithelial damage could be involved in patients with negative Ro and negative biopsy, in whom the term Sjögren “syndrome” seems more adequate.</description><subject>Allergology</subject><subject>Anemia</subject><subject>Antibodies, Antinuclear - immunology</subject><subject>Antinuclear antibodies</subject><subject>Arthritis</subject><subject>Autoantibodies</subject><subject>Autoantibodies - immunology</subject><subject>Biopsy</subject><subject>Cell survival</subject><subject>Classification</subject><subject>Cranial nerves</subject><subject>Cryoglobulinemia</subject><subject>double prime B-cell lymphoma</subject><subject>Erythrocytes</subject><subject>Female</subject><subject>Fever</subject><subject>Humans</subject><subject>Hypergammaglobulinemia</subject><subject>Immunology</subject><subject>Internal Medicine</subject><subject>Leukopenia</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Peripheral neuropathy</subject><subject>Practice Guidelines as Topic</subject><subject>Reviews</subject><subject>Rheumatoid factor</subject><subject>Sedimentation</subject><subject>Sjogren's syndrome</subject><subject>Sjogren's Syndrome - classification</subject><subject>Sjogren's Syndrome - diagnosis</subject><subject>Sjogren's Syndrome - immunology</subject><subject>Vasculitis</subject><issn>1080-0549</issn><issn>1559-0267</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkctu1DAUhi0Eohd4ADZgsekqcGzHtxWC4dJKlVhMu7Y8ycngURIXO1lMH4wX4MXwKKNWYgELy9bx9__nHP2EvGLwjgHo95lxYKoCsJVhklf3T8gpk9JWwJV-Wt5goAJZ2xNylvMOgIMR9jk5YVZqY606Jbv17vevbcKRrvdjm-KANCb6UPwcMvqMH-jND6SXIU-xj9vQ-J76saVXwzCPD5VPwWe68nPGlm72dCoKXlrSVQoTpuBfkGed7zO-PN7n5Pbrl5vVZXX9_dvV6uN11dRcTVWZDWXXNqLphJRlA6lqZGBrqRuuUXcWjJetsnVdBJ3w6EFLAcpvaqkYiHNysfjepfhzxjy5IeQG-96PGOfsrKyVEcza_5JaCCF1aVzIt3-RuzinsazhLDBjmGEHiC1Qk2LOCTt3l8Lg094xcIfA3BKYK4G5Q2DuvmheH43nzYDto-KYUAH4AuTyNW4xPXb-l-ubRdT56Pw2hexu1wUSZVYueDl_AAtbqQ8</recordid><startdate>20100401</startdate><enddate>20100401</enddate><creator>Ramos-Casals, Manuel</creator><creator>Brito-Zerón, Pilar</creator><creator>Perez-De-Lis, Marta</creator><creator>Jimenez, Iratxe</creator><creator>Blanco, Maria-Jose</creator><creator>Bove, Albert</creator><creator>Soto, Maria-Jose</creator><creator>Akasbi, Miriam</creator><creator>Diaz, Candido</creator><creator>Sentís, Juan</creator><creator>Siso, Antoni</creator><general>New York : Humana Press Inc</general><general>Humana Press Inc</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100401</creationdate><title>Sjögren Syndrome or Sjögren Disease? The Histological and Immunological Bias Caused by the 2002 Criteria</title><author>Ramos-Casals, Manuel ; Brito-Zerón, Pilar ; Perez-De-Lis, Marta ; Jimenez, Iratxe ; Blanco, Maria-Jose ; Bove, Albert ; Soto, Maria-Jose ; Akasbi, Miriam ; Diaz, Candido ; Sentís, Juan ; Siso, Antoni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-195e5fdc3cf355080564e109457c27e7f908a5d6944c42f3aea075306ab456103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Allergology</topic><topic>Anemia</topic><topic>Antibodies, Antinuclear - immunology</topic><topic>Antinuclear antibodies</topic><topic>Arthritis</topic><topic>Autoantibodies</topic><topic>Autoantibodies - immunology</topic><topic>Biopsy</topic><topic>Cell survival</topic><topic>Classification</topic><topic>Cranial nerves</topic><topic>Cryoglobulinemia</topic><topic>double prime B-cell lymphoma</topic><topic>Erythrocytes</topic><topic>Female</topic><topic>Fever</topic><topic>Humans</topic><topic>Hypergammaglobulinemia</topic><topic>Immunology</topic><topic>Internal Medicine</topic><topic>Leukopenia</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Peripheral neuropathy</topic><topic>Practice Guidelines as Topic</topic><topic>Reviews</topic><topic>Rheumatoid factor</topic><topic>Sedimentation</topic><topic>Sjogren's syndrome</topic><topic>Sjogren's Syndrome - classification</topic><topic>Sjogren's Syndrome - diagnosis</topic><topic>Sjogren's Syndrome - immunology</topic><topic>Vasculitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramos-Casals, Manuel</creatorcontrib><creatorcontrib>Brito-Zerón, Pilar</creatorcontrib><creatorcontrib>Perez-De-Lis, Marta</creatorcontrib><creatorcontrib>Jimenez, Iratxe</creatorcontrib><creatorcontrib>Blanco, Maria-Jose</creatorcontrib><creatorcontrib>Bove, Albert</creatorcontrib><creatorcontrib>Soto, Maria-Jose</creatorcontrib><creatorcontrib>Akasbi, Miriam</creatorcontrib><creatorcontrib>Diaz, Candido</creatorcontrib><creatorcontrib>Sentís, Juan</creatorcontrib><creatorcontrib>Siso, Antoni</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical reviews in allergy &amp; immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramos-Casals, Manuel</au><au>Brito-Zerón, Pilar</au><au>Perez-De-Lis, Marta</au><au>Jimenez, Iratxe</au><au>Blanco, Maria-Jose</au><au>Bove, Albert</au><au>Soto, Maria-Jose</au><au>Akasbi, Miriam</au><au>Diaz, Candido</au><au>Sentís, Juan</au><au>Siso, Antoni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sjögren Syndrome or Sjögren Disease? The Histological and Immunological Bias Caused by the 2002 Criteria</atitle><jtitle>Clinical reviews in allergy &amp; immunology</jtitle><stitle>Clinic Rev Allerg Immunol</stitle><addtitle>Clin Rev Allergy Immunol</addtitle><date>2010-04-01</date><risdate>2010</risdate><volume>38</volume><issue>2-3</issue><spage>178</spage><epage>185</epage><pages>178-185</pages><issn>1080-0549</issn><eissn>1559-0267</eissn><abstract>The current 2002 classification criteria do not cover the broad clinical and immunological heterogeneity of primary Sjögren syndrome (SS), since five of the six criteria focus exclusively on glandular involvement and the remaining criterion is the mandatory presence of anti-Ro/La antibodies. The aim of this study was to analyze the clinical features of patients with a well-established diagnosis of primary SS who do not fulfill the 2002 classification criteria. Five hundred seven patients diagnosed with primary SS (1993 criteria) were consecutively included and followed up. Two hundred twenty-one (44%) patients did not fulfill the 2002 criteria. These patients were older at diagnosis (p &lt; 0.001) and had a lower frequency of parotid enlargement (p = 0.002), fever (p = 0.041), arthritis (p = 0.041), vasculitis (p = 0.050), peripheral neuropathy (p = 0.002), cranial nerve involvement (p = 0.015), raised erythrocyte sedimentation rate ( ESR) levels (p &lt; 0.001), anemia (p &lt; 0.001), leukopenia (p = 0.037), hypergammaglobulinemia (p &lt; 0.001), positive rheumatoid factor ( RF; p = 0.002), and cryoglobulinemia (p = 0.049) in comparison with those fulfilling 2002 criteria. However, there were no significant differences in the prevalence of sicca features, diagnostic tests, overall systemic involvement, antinuclear antibodies , complement levels, development of B-cell lymphoma, or survival. Patients with anti-Ro antibodies had the highest frequencies of systemic features, hematological abnormalities, and altered immunological markers. In conclusion, patients fulfilling the 2002 criteria, who have either a specific histological diagnosis (lymphocytic infiltration) or highly specific autoantibodies (Ro/La), might well be considered to have Sjögren “disease.” In contrast, etiopathogenic mechanisms other than lymphocytic-mediated epithelial damage could be involved in patients with negative Ro and negative biopsy, in whom the term Sjögren “syndrome” seems more adequate.</abstract><cop>New York</cop><pub>New York : Humana Press Inc</pub><pmid>19578996</pmid><doi>10.1007/s12016-009-8152-z</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1080-0549
ispartof Clinical reviews in allergy & immunology, 2010-04, Vol.38 (2-3), p.178-185
issn 1080-0549
1559-0267
language eng
recordid cdi_proquest_miscellaneous_954683199
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Allergology
Anemia
Antibodies, Antinuclear - immunology
Antinuclear antibodies
Arthritis
Autoantibodies
Autoantibodies - immunology
Biopsy
Cell survival
Classification
Cranial nerves
Cryoglobulinemia
double prime B-cell lymphoma
Erythrocytes
Female
Fever
Humans
Hypergammaglobulinemia
Immunology
Internal Medicine
Leukopenia
Male
Medicine
Medicine & Public Health
Middle Aged
Peripheral neuropathy
Practice Guidelines as Topic
Reviews
Rheumatoid factor
Sedimentation
Sjogren's syndrome
Sjogren's Syndrome - classification
Sjogren's Syndrome - diagnosis
Sjogren's Syndrome - immunology
Vasculitis
title Sjögren Syndrome or Sjögren Disease? The Histological and Immunological Bias Caused by the 2002 Criteria
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T00%3A39%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sj%C3%B6gren%20Syndrome%20or%20Sj%C3%B6gren%20Disease?%20The%20Histological%20and%20Immunological%20Bias%20Caused%20by%20the%202002%20Criteria&rft.jtitle=Clinical%20reviews%20in%20allergy%20&%20immunology&rft.au=Ramos-Casals,%20Manuel&rft.date=2010-04-01&rft.volume=38&rft.issue=2-3&rft.spage=178&rft.epage=185&rft.pages=178-185&rft.issn=1080-0549&rft.eissn=1559-0267&rft_id=info:doi/10.1007/s12016-009-8152-z&rft_dat=%3Cproquest_cross%3E954683199%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=901881817&rft_id=info:pmid/19578996&rfr_iscdi=true